Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.82 USD | -1.42% | -7.80% | -35.63% |
May. 13 | HC Wainwright Adjusts Price Target on Verona Pharma to $30 From $32, Maintains Buy Rating | MT |
May. 09 | Verona Pharma Signs Financing Agreements for Up to $650 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.63% | 1.05B | |
+9.74% | 115B | |
+11.91% | 106B | |
-2.56% | 21.96B | |
-13.76% | 21.87B | |
-5.29% | 19.21B | |
-3.39% | 18.08B | |
-38.57% | 17.71B | |
+6.25% | 14.32B | |
+34.55% | 12.42B |
- Stock Market
- Equities
- VRNA Stock
- News Verona Pharma plc
- Verona Pharma Shares Decline After Q1 Loss Widens